Experimental study on inhibition of corneal neovascularization with recombinant human secretory endostatin
MA Chun-hong
Abstract
MA Chun-hong
Abstract
Objective:To study the inhibition effects of recombinant human secretory endostatin on corneal neovascularization of rabbits.Methods:Stitching cornea was used to induce the formation of corneal neovascularization in rabbits.On the first day after manipulation,recombinant endostatin and nor-mal saline were separatively injected into subconjunctival tissues to observe the growth of corneal neovas-cularization and histopathological changes.Results:Endostatin treatment group showed shorter elongations and smaller areas of new blood vessels than normal saline group.Moreover,fewer neovascularities,plasmo-cytes and fibroblasts in endostatin treatment group were observed under the light microscope(P0.05).Con-clusion:The results indicated that the subconjunctival injection of recombinant endostatin could inhibit the growth of corneal neovascularization,which will provide a new method for the prevention and treatment of corneal neovascularization in clinic.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To study the inhibition effects of recombinant human secretory endostatin on corneal neovascularization of rabbits.Methods:Stitching cornea was used to induce the formation of corneal neovascularization in rabbits.On the first day after manipulation,recombinant endostatin and nor-mal saline were separatively injected into subconjunctival tissues to observe the growth of corneal neovas-cularization and histopathological changes.Results:Endostatin treatment group showed shorter elongations and smaller areas of new blood vessels than normal saline group.Moreover,fewer neovascularities,plasmo-cytes and fibroblasts in endostatin treatment group were observed under the light microscope(P0.05).Con-clusion:The results indicated that the subconjunctival injection of recombinant endostatin could inhibit the growth of corneal neovascularization,which will provide a new method for the prevention and treatment of corneal neovascularization in clinic.
Key concepts: Endostatin, Corneal neovascularization, Neovascularization, Cornea, Saline, Recombinant DNA, Ophthalmology, Medicine